Ravulizumab and COVID-19

Clinical trial NCT04570397 · UNKNOWN

Trial details

NCT number: NCT04570397
Sponsor: Brigham and Women's Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 Thrombotic Microangiopathies Acute Kidney Injury

Start date: 2020-12-18
Primary completion: 2023-05-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.